A carregar...
FTC Versus Congress: The Biosimilars Debate
A Federal Trade Commission report dismissed the need for a period of market exclusivity for brand-name biologics that may face follow-on competition. The authors argue that the FTC’s conclusion –that patent protection alone will fuel biotech R&D after passage of follow-on legislation – is shaky....
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioCommunications LLC
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2799095/ https://ncbi.nlm.nih.gov/pubmed/22478787 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|